Heron Therapeutics Inc.

NASDAQ: HRTX · Real-Time Price · USD
1.33
-0.02 (-1.48%)
At close: Aug 15, 2025, 3:59 PM
1.33
-0.23%
After-hours: Aug 15, 2025, 05:03 PM EDT

Heron Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-17.18 -2.12 -1.5 -4.07
PEG Ratio
0.19 0.04 0.06 0.39
PS Ratio
1.62 1.85 2.53 10.41
PB Ratio
-6.93 -6.91 20.06 11.59
P/FCF Ratio
-9.62 -3.89 -1.83 -4.36
P/OCF Ratio
-10.35 -3.99 -1.85 -4.42
OCF/S Ratio
-0.16 -0.46 -1.36 -2.36
Debt / Equity Ratio
-5.28 -5.29 11.60 2.06
Quick Ratio
1.70 1.84 1.83 2.90
Current Ratio
2.29 2.37 2.49 3.58
Asset Turnover
0.62 0.57 0.43 0.28
Interest Coverage
-1.91 -28.6 -70.6 -90.39
Return on Equity
0.40 3.25 -13.41 -2.84
Return on Assets
-0.06 -0.5 -0.73 -0.72
Return on Invested Capital
-0.08 -0.74 -0.74 -0.9
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.73 0.49 0.49 0.47
Net Profit Margin
-0.09 -0.87 -1.69 -2.56
Pretax Profit Margin
-0.09 -0.87 -1.69 -2.56
Operating Profit Margin
-0.08 -0.87 -1.62 -2.52
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-0.04 -0.82 -1.64 -2.49